Newsfile Corp
11 Jun 2026, 23:35 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
The NHS-Galleri trial as executed was reportedly insufficient to demonstrate a reduction in Stage III-IV cancers. — Failure to meet primary endpoints in a major clinical trial directly undermines the company's primary value proposition and future revenue potential.
-0.80GRAIL, Inc. is facing a class action lawsuit alleging it concealed material adverse facts regarding the NHS-Galleri trial results. — Allegations of fraud and misleading statements regarding core product efficacy typically lead to investor distrust and potential legal liabilities.
-0.60GRAIL allegedly refused to provide detailed topline results or data from the NHS-Galleri study to hide unfavorable trendlines. — Lack of transparency regarding clinical data suggests a higher risk of failure and potential regulatory hurdles.
-0.40Which stocks this story touches
Continue reading
6 related stories
Top 3 movers · tap to explore
The company is facing a class action lawsuit alleging it issued false and misleading statements regarding its NHS-Galleri trial.
The company is mentioned in the context of a securities class action investigation.
The company is mentioned in the context of a securities class action lawsuit with an upcoming deadline.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
GlobeNewsWire
2h ago
